Acromegalic cardiomyopathy: a review of the literature

Pituitary
M P Matta, P Caron

Abstract

Acromegaly is characterized by a high prevalence of cardiovascular complications that account for increased morbidity and mortality. Several studies emphasized the role of GH and IGF-1 excess in cardiac dysfunction. Coexisting factors such as hypertension, glucose tolerance abnormalities and coronary artery disease have a potential role in the progression of the acromegalic cardiomyopathy. Herein, we review the most relevant pathophysiological, functional and morphological findings in this specific disease.

Citations

Nov 15, 2012·Endocrine·Mustafa UnubolCagdas Akgullu
Jan 7, 2006·Postgraduate Medical Journal·J Ayuk, M C Sheppard
May 29, 2008·Endocrine Journal·Haruna SakaiYukio Hirata
Jun 24, 2006·The Kaohsiung Journal of Medical Sciences·Ming-Ying LuSheng-Hsiung Sheu
Mar 20, 2012·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Guillermo Serra SolerVicente Pereg Macazaga
Nov 3, 2005·The Journal of Clinical Endocrinology and Metabolism·Eugenia ResminiFrancesco Minuto
May 26, 2018·Cardiology in Review·Michael D GoldbergWilliam H Frishman
Jul 26, 2017·Methodist DeBakey Cardiovascular Journal·Morali D SharmaRichard J Robbins

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.

Related Papers

Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición
David Clemente GallegoTomás Lucas Morante
Neuroendocrinology
Gaetano LombardiA Colao
© 2022 Meta ULC. All rights reserved